• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨噬细胞抑制因子-1 通过激活 SK-BR-3 人乳腺癌细胞中的Src 转激活 ErbB 家族受体。

Macrophage inhibitory cytokine-1 transactivates ErbB family receptors via the activation of Src in SK-BR-3 human breast cancer cells.

机构信息

Departments of Biochemistry and College of Natural Sciences, Kangwon National University, Chuncheon 200-701, Korea.

出版信息

BMB Rep. 2010 Feb;43(2):91-6. doi: 10.5483/bmbrep.2010.43.2.091.

DOI:10.5483/bmbrep.2010.43.2.091
PMID:20193126
Abstract

The function of macrophage inhibitory cytokine-1 (MIC-1) in cancer remains controversial, and its signaling pathways remain poorly understood. In this study, we demonstrate that MIC-1 induces the transactivation of EGFR, ErbB2, and ErbB3 through the activation of c-Src in SK-BR-3 breast cells. MIC-1 induced significant phosphorylation of EGFR at Tyr845, ErbB2 at Tyr877, and ErbB3 at Tyr1289 as well as Akt and p38, Erk1/2, and JNK mitogen-activated protein kinases (MAPKs). Treatment of SK-BR-3 cells with MIC-1 increased the phosphorylation level of Src at Tyr416, and induced invasiveness of those cells. Inhibition of c-Src activity resulted in the complete abolition of MIC-1-induced phosphorylation of the EGFR, ErbB2, and ErbB3, as well as invasiveness and matrix metalloproteinase (MMP)-9 expression in SK-BR-3 cells. Collectively, these results show that MIC-1 may participate in the malignant progression of certain cancer cells through the activation of c-Src, which in turn may transactivate ErbB-family receptors.

摘要

巨噬细胞抑制细胞因子-1(MIC-1)在癌症中的功能仍存在争议,其信号通路也知之甚少。在这项研究中,我们证明 MIC-1 通过激活 SK-BR-3 乳腺癌细胞中的 c-Src 诱导 EGFR、ErbB2 和 ErbB3 的转激活。MIC-1 诱导 EGFR 在 Tyr845、ErbB2 在 Tyr877 和 ErbB3 在 Tyr1289 以及 Akt 和 p38、Erk1/2 和 JNK 丝裂原激活蛋白激酶(MAPKs)的显著磷酸化。用 MIC-1 处理 SK-BR-3 细胞可增加 Src 在 Tyr416 处的磷酸化水平,并诱导这些细胞的侵袭性。抑制 c-Src 活性可导致 MIC-1 诱导的 EGFR、ErbB2 和 ErbB3 的磷酸化以及 SK-BR-3 细胞的侵袭性和基质金属蛋白酶(MMP)-9 表达完全消除。总之,这些结果表明 MIC-1 可能通过激活 c-Src 参与某些癌细胞的恶性进展,而 c-Src 又可能转激活 ErbB 家族受体。

相似文献

1
Macrophage inhibitory cytokine-1 transactivates ErbB family receptors via the activation of Src in SK-BR-3 human breast cancer cells.巨噬细胞抑制因子-1 通过激活 SK-BR-3 人乳腺癌细胞中的Src 转激活 ErbB 家族受体。
BMB Rep. 2010 Feb;43(2):91-6. doi: 10.5483/bmbrep.2010.43.2.091.
2
Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells.巨噬细胞抑制细胞因子-1通过激活人乳腺癌和胃癌细胞中的ErbB2反式激活来激活AKT和ERK-1/2。
Carcinogenesis. 2008 Apr;29(4):704-12. doi: 10.1093/carcin/bgn031. Epub 2008 Feb 6.
3
Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells.表皮生长因子受体、c-erbB2和c-erbB3受体相互作用以及SK-BR-3和BT474乳腺癌细胞的相关细胞周期动力学
Cytometry. 2001 Aug 1;44(4):338-48. doi: 10.1002/1097-0320(20010801)44:4<338::aid-cyto1125>3.0.co;2-v.
4
Macrophages stimulate gastric and colorectal cancer invasion through EGFR Y(1086), c-Src, Erk1/2 and Akt phosphorylation and smallGTPase activity.巨噬细胞通过表皮生长因子受体(EGFR)Y(1086)、c-Src、细胞外信号调节激酶1/2(Erk1/2)和蛋白激酶B(Akt)磷酸化以及小GTP酶活性刺激胃癌和结直肠癌的侵袭。
Oncogene. 2014 Apr 17;33(16):2123-33. doi: 10.1038/onc.2013.154. Epub 2013 May 6.
5
Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cells.孕激素受体上调Wnt-1,以诱导表皮生长因子受体反式激活以及c-Src依赖的乳腺癌细胞中细胞外信号调节激酶1/2(Erk1/2)丝裂原活化蛋白激酶的持续激活。
Mol Cell Biol. 2007 Jan;27(2):466-80. doi: 10.1128/MCB.01539-06. Epub 2006 Oct 30.
6
Aplidin induces apoptosis in human cancer cells via glutathione depletion and sustained activation of the epidermal growth factor receptor, Src, JNK, and p38 MAPK.阿普立丁通过消耗谷胱甘肽以及持续激活表皮生长因子受体、Src、JNK和p38丝裂原活化蛋白激酶,诱导人癌细胞凋亡。
J Biol Chem. 2003 Jan 3;278(1):241-50. doi: 10.1074/jbc.M201010200. Epub 2002 Oct 31.
7
Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation.代偿性ErbB3/c-Src信号传导增强癌细胞对电离辐射的存活能力。
Breast Cancer Res Treat. 2006 Jan;95(1):17-27. doi: 10.1007/s10549-005-9023-9.
8
Antitumor effects of berberine against EGFR, ERK1/2, P38 and AKT in MDA-MB231 and MCF-7 breast cancer cells using molecular modelling and in vitro study.小檗碱通过分子建模和体外研究对 MDA-MB231 和 MCF-7 乳腺癌细胞中 EGFR、ERK1/2、P38 和 AKT 的抗肿瘤作用。
Pharmacol Rep. 2019 Feb;71(1):13-23. doi: 10.1016/j.pharep.2018.07.005. Epub 2018 Aug 1.
9
c-Src-p38 mitogen-activated protein kinase signaling is required for Akt activation in response to ionizing radiation.c-Src-p38丝裂原活化蛋白激酶信号传导是电离辐射诱导Akt激活所必需的。
Mol Cancer Res. 2008 Dec;6(12):1872-80. doi: 10.1158/1541-7786.MCR-08-0084.
10
Interacting post-muscarinic receptor signaling pathways potentiate matrix metalloproteinase-1 expression and invasion of human colon cancer cells.毒蕈碱受体后相互作用的信号通路增强人结肠癌细胞中基质金属蛋白酶-1的表达及侵袭能力。
Biochem J. 2017 Feb 20;474(5):647-665. doi: 10.1042/BCJ20160704.

引用本文的文献

1
GDF-15 Inhibits ADP-Induced Human Platelet Aggregation through the GFRAL/RET Signaling Complex.GDF-15 通过 GFRAL/RET 信号复合物抑制 ADP 诱导的人血小板聚集。
Biomolecules. 2023 Dec 27;14(1):38. doi: 10.3390/biom14010038.
2
Bone morphogenetic proteins, activins, and growth and differentiation factors in tumor immunology and immunotherapy resistance.骨形态发生蛋白、激活素、生长分化因子在肿瘤免疫和免疫治疗耐药中的作用。
Front Immunol. 2022 Oct 24;13:1033642. doi: 10.3389/fimmu.2022.1033642. eCollection 2022.
3
Ferroptosis: Cancer Stem Cells Rely on Iron until "to Die for" It.
铁死亡:癌症干细胞依赖铁,直至“为之而死”。
Cells. 2021 Nov 2;10(11):2981. doi: 10.3390/cells10112981.
4
c-Src and EGFR Inhibition in Molecular Cancer Therapy: What Else Can We Improve?分子癌症治疗中c-Src和表皮生长因子受体(EGFR)抑制:我们还能改进什么?
Cancers (Basel). 2020 Jun 7;12(6):1489. doi: 10.3390/cancers12061489.
5
Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint.生长/分化因子 15(GDF-15):从生物标志物到新型可靶向免疫检查点。
Front Immunol. 2020 May 19;11:951. doi: 10.3389/fimmu.2020.00951. eCollection 2020.
6
High ErbB3 activating activity in human blood is not due to circulating neuregulin-1 beta.人血液中高的 ErbB3 激活活性并非由于循环神经调节蛋白-1β。
Life Sci. 2020 Jun 15;251:117634. doi: 10.1016/j.lfs.2020.117634. Epub 2020 Apr 3.
7
GDF-15 in solid vs non-solid treatment-naïve malignancies.固体与非固体治疗初治恶性肿瘤中的 GDF-15。
Eur J Clin Invest. 2019 Nov;49(11):e13168. doi: 10.1111/eci.13168. Epub 2019 Sep 26.
8
Contribution of three-dimensional architecture and tumor-associated fibroblasts to hepcidin regulation in breast cancer.三维结构和肿瘤相关成纤维细胞对乳腺癌中血红素调节的贡献。
Oncogene. 2018 Jul;37(29):4013-4032. doi: 10.1038/s41388-018-0243-y. Epub 2018 Apr 26.
9
Growth differentiation factor 15 mediates epithelial mesenchymal transition and invasion of breast cancers through IGF-1R-FoxM1 signaling.生长分化因子15通过IGF-1R-FoxM1信号传导介导乳腺癌的上皮-间质转化和侵袭。
Oncotarget. 2017 Oct 10;8(55):94393-94406. doi: 10.18632/oncotarget.21765. eCollection 2017 Nov 7.
10
Quantitative label-free proteomic analysis of human urine to identify novel candidate protein biomarkers for schistosomiasis.对人尿液进行无标记定量蛋白质组学分析,以鉴定血吸虫病新的候选蛋白质生物标志物。
PLoS Negl Trop Dis. 2017 Nov 8;11(11):e0006045. doi: 10.1371/journal.pntd.0006045. eCollection 2017 Nov.